실험실 정보 시스템 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the laboratory information system market size is projected to expand from USD 2.34 billion in 2025 and USD 2.65 billion in 2026 to USD 4.90 billion by 2031, registering a CAGR of 13.08% between 2026 to 2031.

This report is Segmented by Component (Software [Stand-Alone LIS and More] and Service [Implementation & Integration and More]), Mode of Delivery (On-Premise, and More), Laboratory Type (Clinical Pathology Labs, and More), End User (Hospital and Clinics, and More), and Geography ( North America, Europe, Asia-Pacific, More). The Market Provides the Value (in USD Million) for the Above Segments.

Global Laboratory Information System Market Trends and Insights

Rising Global Diagnostic Testing Volumes

Worldwide specimen volumes are climbing 6-8% annually as aging populations, chronic disease screening, and public-health mandates stretch manual workflows. Europe's largest chain, SYNLAB, processed more than 600 million tests in 2024 and cut pre-analytical errors by 18% after automating triage through its LIS. Next-generation sequencing runs now generate gigabytes of data per patient, compelling laboratories to deploy bioinformatics-ready LIS modules. In India, Dr. Lal PathLabs manages logistics for 2,500 laboratories and 4,000 collection centers through a centralized cloud LIS that supports 12-15% annual volume growth. Rising throughput is also boosting demand for AI auto-verification that trims routine chemistry turnaround times by up to 30%.

Rapid Scale-Up of Biobank Networks

Precision-medicine initiatives are spawning national biobanks that require long-term specimen tracking, consent management, and multi-omics linkage. The UK Biobank finished whole-genome sequencing for 500,000 participants in 2024, a milestone that depends on federated LIS query capabilities . Europe's Genome of Europe project and the U.S. All of Us Program rely on cloud-native LIS layers that meet ISO 20387 standards while supporting GDPR-compliant pseudonymization. SaaS LIS vendors offering pre-validated chain-of-custody modules are therefore seeing strong inbound interest from academic consortia and regional research centers.

High Total Cost of Ownership

Mid-size laboratories with 100-500 daily accessions spend USD 150,000-400,000 per year on licenses, interfaces, and IT support. Per-analyzer interface fees of USD 5,000-15,000 erode margins, while cloud subscription costs scale with data retention. Consulting for FHIR mapping or custom reports can exceed USD 200 per hour, and training now represents 20-25% of go-live budgets.

Other drivers and restraints analyzed in the detailed report include:

1. Cloud/SaaS LIS Lowering Capital Outlays
2. AI-Powered Workflow Automation Modules
3. Escalating Cybersecurity & HIPAA/GDPR Liabilities

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Services contributed 60.05% of the laboratory information system market in 2025, and their revenue is projected to rise 13.99% annually through 2031. The laboratory information system market size for services is growing because laboratories require FHIR mapping, AI validation, and multi-site cloud orchestration. SaaS platforms are eroding perpetual-license software sales, but longer implementation cycles push consulting and managed-services demand.

Managed support contracts now bundle security patching, disaster recovery, and accreditation reporting, converting previously discretionary spend into recurring fees. Vendors offering pre-validated templates win faster deals, while training engagements aligned with ISO 15189 audits keep consulting pipelines full.

Cloud models controlled 54.32% of the laboratory information system market share in 2025. Elastic infrastructure lets laboratories scale influenza testing surges without over-provisioning hardware, and built-in FHIR endpoints simplify compliance. The laboratory information system market size tied to on-premise installations is shrinking as server refresh and cybersecurity costs climb.

Hybrid deployments remain relevant where data-localization laws restrict cross-border transfer, allowing sensitive genomic data to stay on-site while administrative modules run in the cloud. Vendors secure a competitive advantage by offering HIPAA Business Associate Agreements and country-specific GDPR hosting zones.

Complete Report Scope:

• By Component
  • Software
    • Stand-alone LIS
    • Integrated LIS / EHR-centric
    • SaaS LIS Platforms
  • Services
    • Implementation & Integration
    • Maintenance & Support
    • Training & Consulting
• By Mode of Delivery
  • On-Premise
  • Cloud-Based
  • Hybrid
• By Laboratory Type
  • Clinical Pathology Labs
  • Anatomic Pathology Labs
  • Molecular Diagnostics Labs
  • Blood Banks & Biobanks
  • Other Specialized Labs
• By End User
  • Hospitals & Clinics
  • Laboratories
  • Academic & Research Institutes
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 43.57% of 2025 revenue, reflecting high installed-base maturity and early regulatory triggers. The United States leads upgrades as laboratories race to meet the January 2027 FHIR mandate, while Canada's provincial health authorities fund consolidated cloud rollouts to harmonize result sharing. Mexico shows steady gains as private diagnostic firms expand into secondary cities, though currency volatility tempers capital budgets.

Asia-Pacific is projected to post 14.42% CAGR, the fastest regional expansion in the laboratory information system market. India's ISO 15189 accreditation drive and China's Healthy China 2030 program are digitizing tertiary hospital labs . Diagnostic chains such as Dr. Lal PathLabs leverage cloud LIS to monitor 2,500 labs in real time, promoting standardized SOPs across tier-2 and tier-3 cities. Japan and Australia invest in national health information exchanges that embed LIS result feeds.

Europe enjoys stable uptake as the Health Data Space regulation mandates cross-border laboratory interoperability. Germany, with more than 1,800 hospital labs, leads cloud migration to comply with Medical Device Regulation software clauses. The United Kingdom consolidates pathology services into 29 regional networks that issue unified LIS tenders to cut costs and improve turnaround. France, Italy, and Spain follow similar digitization arcs, synchronized with phased EHDS deadlines through 2031.

1. Aspyra, LLC
2. Cirdan
3. Clinisys, Inc.
4. Comp Pro Med
5. CompuGroup Medical
6. Creliohealth
7. Dedalus Global
8. Dendi Software
9. EasySolution
10. Epic Systems Corporation.
11. GPI Spa
12. LigoLab Information Systems
13. NovoPath
14. Oracle
15. Osplabs
16. Prolis LIS
17. Soft Computer Consultants.
18. Sysmex
19. Werfen, S.A.
20. XiFin, Inc.
21. eLabNext B.V.
22. CGM SCHUYLAB
23. SoftTech Health LLC

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Global Diagnostic Testing Volumes
  • 4.2.2 Rapid Scale-Up Of Biobank Networks
  • 4.2.3 Cloud/SaaS LIS Lowering Capital Outlays
  • 4.2.4 AI-Powered Workflow Automation Modules
  • 4.2.5 Mandatory LIS-EHR Interoperability
  • 4.2.6 Edge-LIS Micro-Appliances
• 4.3 Market Restraints
  • 4.3.1 High Total Cost of Ownership
  • 4.3.2 Escalating Cybersecurity Liabilities
  • 4.3.3 Shortage Of LIS-Literate Informaticians
  • 4.3.4 Volatile Open-API Standards
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD Million)

• 5.1 By Component
  • 5.1.1 Software
    • 5.1.1.1 Stand-alone LIS
    • 5.1.1.2 Integrated LIS / EHR-centric
    • 5.1.1.3 SaaS LIS Platforms
  • 5.1.2 Services
    • 5.1.2.1 Implementation & Integration
    • 5.1.2.2 Maintenance & Support
    • 5.1.2.3 Training & Consulting
• 5.2 By Mode of Delivery
  • 5.2.1 On-Premise
  • 5.2.2 Cloud-Based
  • 5.2.3 Hybrid
• 5.3 By Laboratory Type
  • 5.3.1 Clinical Pathology Labs
  • 5.3.2 Anatomic Pathology Labs
  • 5.3.3 Molecular Diagnostics Labs
  • 5.3.4 Blood Banks & Biobanks
  • 5.3.5 Other Specialized Labs
• 5.4 By End User
  • 5.4.1 Hospitals & Clinics
  • 5.4.2 Laboratories
  • 5.4.3 Academic & Research Institutes
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of APAC
  • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Aspyra, LLC
  • 6.3.2 Cirdan
  • 6.3.3 Clinisys, Inc.
  • 6.3.4 Comp Pro Med
  • 6.3.5 CompuGroup Medical
  • 6.3.6 Creliohealth
  • 6.3.7 Dedalus Global
  • 6.3.8 Dendi Software
  • 6.3.9 EasySolution
  • 6.3.10 Epic Systems Corporation.
  • 6.3.11 GPI Spa
  • 6.3.12 LigoLab Information Systems
  • 6.3.13 NovoPath
  • 6.3.14 Oracle Corporation
  • 6.3.15 Osplabs
  • 6.3.16 Prolis LIS
  • 6.3.17 Soft Computer Consultants.
  • 6.3.18 Sysmex Corporation
  • 6.3.19 Werfen, S.A.
  • 6.3.20 XiFin, Inc.
  • 6.3.21 eLabNext B.V.
  • 6.3.22 CGM SCHUYLAB
  • 6.3.23 SoftTech Health LLC

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment